J. Hoyer

发表

Central Iliac Arteriovenous Anastomosis for Uncontrolled Hypertension: One-Year Results From the ROX CONTROL HTN Trial

A. Stanton, E. Dolan, R. Schmieder, 2017, Hypertension.

Interventionelle renale Sympathikusdenervation zur Behandlung der therapieresistenten Hypertonie Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment

M. Böhm, R. Schmieder, H. Bruck, 2011 .

Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus.

P. Galle, P. Rácz, C. Rupprecht, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Kidney Hypertrophy in Living Kidney Donors and Their Corresponding Recipients.

J. Figiel, J. Hoyer, Kilian Steden, 2022, Transplantation proceedings.

Phenprocoumon based anticoagulation is an underestimated factor in the pathogenesis of calciphylaxis

P. Russ, J. Hoyer, B. Kortus-Goetze, 2019, BMC Nephrology.

Repeated kidney re‐transplantation—the Eurotransplant experience: a retrospective multicenter outcome analysis

K. Lopau, A. Rahmel, Katharina Selig, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

Tetrahydrobiopterin deficiency in human rabies

C. Rupprecht, C. Drosten, R. Willoughby, 2009, Journal of Inherited Metabolic Disease.

[Dialysis and ultrafiltration therapy in patients with cardio-renal syndrome: recommendations of the working group "heart-kidney" of the German Cardiac Society and the German Society of Nephrology].

H. Schunkert, R. Schmieder, U. Hoppe, 2014, Deutsche medizinische Wochenschrift.

Clinical and Immunological Follow-Up of Pemphigus Patients on Adjuvant Treatment with Immunoadsorption or Rituximab

R. Eming, M. Hertl, U. Kuhlmann, 2008, Dermatology.

Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult‐to‐treat pemphigus vulgaris

R. Eming, M. Hertl, C. Möbs, 2012, The British journal of dermatology.

Salt restriction for the prevention of cardiovascular disease.

M. Middeke, J. Hoyer, D. Klaus, 2010, Deutsches Arzteblatt international.

A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study

G. Breithardt, J. Gerss, C. Wanner, 2022, Circulation.

Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial

A. Stanton, E. Dolan, R. Schmieder, 2015, The Lancet.

Clinical Pharmacokinetics of Angiotensin Converting Enzyme (ACE) Inhibitors in Renal Failure

K. Schulte, J. Hoyer, T. Lenz, 1993, Clinical pharmacokinetics.

Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study

Peter Bramlage, S. Matthaei, W. Zidek, 2012, Cardiovascular Diabetology.

Diagnostik und Therapie bei therapieresistenter Hypertonie

J. Hoyer, T. Lenz, B. Haubitz, 2013, Der Nephrologe.

First-line antihypertensive treatment in patients with pre-diabetes: Rationale, design and baseline results of the ADaPT investigation

S. Matthaei, W. Zidek, C. Hasslacher, 2008, Cardiovascular diabetology.

Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension

S. Achenbach, A. Stanton, E. Dolan, 2016, Journal of the American Heart Association.

Zero Diffusive Sodium Balance in Hemodialysis Provided by an Algorithm‐Based Electrolyte Balancing Controller: A Proof of Principle Clinical Study

B. Canaud, U. Kuhlmann, M. Gross, 2018, Artificial organs.

Cognitive performance in dialysis patients - "when is the right time to test?"

S. Thiele, J. Hoyer, Brandon H Greene, 2021, BMC Nephrology.

Assessment of cognitive impairment and related risk factors in hemodialysis patients

R. Dodel, J. Hoyer, Jannis Ziemek, 2021, Journal of Nephrology.

Serum proteomics hint at an early T-cell response and modulation of SARS-CoV-2-related pathogenic pathways in COVID-19-ARDS treated with Ruxolitinib

A. Bhagwat, A. Neubauer, H. Mack, 2023, Frontiers in Medicine.

The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)

C. Schade-Brittinger, C. Vogelmeier, A. Neubauer, 2021, Leukemia.

Tunneled central venous catheters for hemodialysis-unfairly condemned? Catheter-related complications in a university hospital setting.

C. Haas, A. Buckenmayer, J. Hoyer, 2023, The journal of vascular access.

O R I G I N a L I N V E S T I G a T I O N Ramipril-based versus Diuretic-based Antihypertensive Primary Treatment in Patients with Pre-diabetes (adapt) Study

S. Matthaei, W. Zidek, C. Hasslacher, 2022 .

Die Beschränkung der Kochsalzaufnahme in der Gesamtbevölkerung verspricht langfristig großen Nutzen

M. Halle, H. Pavenstädt, M. Middeke, 2009, Deutsche medizinische Wochenschrift.